Bio-Connect
WB analysis of HepG2 cell lysate (35ug/lane) using GTX80452 EFEMP2 antibody, C-term.
WB analysis of HepG2 cell lysate (35ug/lane) using GTX80452 EFEMP2 antibody, C-term.
WB analysis of HepG2 cell lysate (35ug/lane) using GTX80452 EFEMP2 antibody, C-term.

EFEMP2 antibody, C-term

GTX80452
GeneTex
TargetEFEMP2
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    EFEMP2 antibody, C-term
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000. FACS: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Formulation
    Liquid
  • Gene ID30008
  • Target name
    EFEMP2
  • Target description
    EGF containing fibulin extracellular matrix protein 2
  • Target synonyms
    ARCL1B; EGF containing fibulin like extracellular matrix protein 2; EGF-containing fibulin-like extracellular matrix protein 2; FBLN4; FIBL-4; fibulin 4; MBP1; mutant p53 binding protein 1; UPH1
  • Protein IDO95967
  • Protein Name
    EGF-containing fibulin-like extracellular matrix protein 2
  • Scientific Description
    A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium-binding EGF2 domains. This gene is necessary for elastic fiber formation and connective tissue development. Defects in this gene are cause of an autosomal recessive cutis laxa syndrome. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jan 2011]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Secretomes reveal several novel proteins as well as TGF-beta1 as the top upstream regulator of metastatic process in breast cancer. Erin N et al., 2018 Jul, Breast Cancer Res Treat
    Read more